Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Keystone Symposium on Growing to Extremes: Cell Biology and Pathology of Axons
"Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS.
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).
Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection.
Development of the Brief Inventory of Perceived Stress.
Fingolimod-A sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes.
22nd Meeting of European Neurological Society
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.
Laquinimod - New Promising Treatment for Multiple Sclerosis
Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Editorial for JNV issue on PML.
Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.
Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial.
Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis.
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
Altered microRNA expression in B lymphocytes in multiple sclerosis: Towards a better understanding of treatment effects.
Function and distribution of three types of rectifying channel in rat spinal root myelinated axons.
Conformational Landscape of N-Glycosylated Peptides Detecting Autoantibodies in Multiple Sclerosis, Revealed by Hamiltonian Replica Exchange.
Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
The effect of the interval-between-sessions on prefrontal transcranial direct current stimulation (tDCS) on cognitive outcomes: a systematic review and meta-analysis.
The value of specialty pharmaceuticals - a systematic review.
Effect of High-Dose Intravenous Methyl-prednisolone Treatment on Intraocular Pressure in Multiple Sclerosis Patients with Relapse.

Pages